A scientific instrument can perform well in evaluation and still struggle to win a place in a laboratory.
The results may be convincing. The team can explain the technology. Researchers may show interest at a conference or ask for more information. Yet that interest does not necessarily become an evaluation, a budget request or an order.
Technical validation establishes something essential about the product. Adoption also depends on the customer’s existing work, the people making the decision and the practical consequences of changing their approach.
Life sciences marketing needs to address those questions before the launch campaign promises more than the buying process can deliver.
The existing method already has a place in the lab
A laboratory may have equipment, protocols, trained staff and years of experience tied to its current approach. People know how to interpret the results and what to do when something goes wrong.
A new product asks them to reconsider some of that work. Even a worthwhile improvement can involve additional evaluation, training, time and explanation to colleagues.
That gives you a useful set of questions to investigate. What would the customer replace? What would stay? Who would need to learn something new? Could the product sit alongside an existing method while the team assesses its usefulness?
The answers affect the proposition. They may also change what you offer as the next step. A well-defined evaluation can be more useful to a cautious buyer than an invitation to a general demonstration.
Find the application where the advantage is worth the effort
When I joined Avacta Analytical, biopharma researchers already had trusted ways to assess protein stability and aggregation. We had an instrument that could deliver answers quickly from tiny samples. Those capabilities gave us a promising starting point, but we needed to establish where they made a meaningful difference.
I developed the positioning, product proposition and marketing strategy around the applications where the advantages mattered most. Working with scientists and academic key opinion leaders, I helped build application-led proof and turn it into campaigns, sales materials and support for international distributors.
The work involved connecting a technical capability to a recognisable research need. A broad claim about speed was less useful than an explanation of which work could benefit and the evidence behind it.
You can read more in the Avacta positioning and product commercialisation case.
An interested scientist may need help making the internal case
The person who understands the product best may not control the budget or the implementation.
A researcher may want better information from limited samples. A laboratory manager may need to understand throughput, staff time and training. A budget holder may ask whether the investment should take priority over another purchase.
Those are reasonable questions. Marketing and Sales can prepare for them together.
Alongside technical evidence, consider whether the prospective customer has a clear explanation of the evaluation process, support available, practical requirements and the basis for any cost or capacity comparison. Use assumptions they can inspect and replace with their own figures.
This is especially useful when your contact has to explain the purchase to someone who has not seen the demonstration.
What life sciences marketing needs to establish before launch
Before committing to a larger campaign, I would want clear answers to five questions:
- Which application comes first? Name the work, audience and circumstances where the product’s advantages are most relevant.
- Why would the customer change? Describe the problem with their current approach and the improvement worth pursuing.
- What does the evidence establish? Be precise about conditions, comparisons and limitations. Identify what still needs to be evaluated.
- What does adoption involve? Explain the practical steps, people, resources and support required.
- What should an interested buyer do next? Make the evaluation, application discussion or commercial conversation specific enough to act on.
If the team gives different answers, a launch brief is a useful place to resolve them. Otherwise, the website, sales presentation and distributor materials can end up describing slightly different offers.
Use early conversations to improve the launch
Once activity begins, look beyond the number of people who respond. Review whether the right applications are appearing, which evidence gets discussed and what happens between interest and evaluation.
A pattern of enquiries from unsuitable applications may point to a targeting or messaging problem. Evaluations that never begin may reveal practical obstacles or a weak internal case. A product that performs well but loses the purchase may need closer investigation of the buying decision.
These are possibilities to test with the people involved. A quiet pipeline alone will not tell you which explanation is right.
Before buying more exposure, review a small set of recent opportunities with Sales and Technical. Trace what the customer needed, what you showed them and where progress stopped. That gives the next campaign a more useful brief.
If you are preparing a scientific product launch, I can help with the positioning, campaign plan and sales support.
Need ongoing direction? Explore fractional marketing director support ↗